Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10640556 | Anti amphiregulin antibodies, compositions comprising same and uses thereof | Silvia CARVALHO, Moshit Lindzen | 2020-05-05 |
| 10526416 | Anti-HER3 antibodies and uses of same | Nadege Gaborit, Moshit Lindzen | 2020-01-07 |
| 10011659 | Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (TKI) | Maicol Mancini, Nadege Gaborit | 2018-07-03 |
| 9926564 | Aptamers, multimeric aptamers and uses thereof | Michael Sela, Georg Mahlknecht, Ruth Maron, Bilha Schechter | 2018-03-27 |
| 9518988 | Antibodies and methods of using same for treating ErbB/ErbB ligands associated diseases | Moshit Lindzen | 2016-12-13 |
| 9415103 | Combination therapy to prevent DCIS formation and progression to breast cancer | Pradeep Chaluvally-Raghavan | 2016-08-16 |
| 9358288 | Antibody combinations and use of same for treating cancer | Michael Sela, Bilha Schechter, Tsipi Ben-Kasus | 2016-06-07 |
| 9040047 | Combinations of anti ErbB antibodies for the treatment of cancer | Michael Sela, Bilha Schechter, Ruth Maron | 2015-05-26 |
| 8883149 | Antibody combinations and use of same for treating cancer | Michael Sela, Bilha Schechter, Tsipi Ben-Kasus | 2014-11-11 |
| 7981997 | Growth factor which acts through ErbB-4 RTK | Daniel Harari | 2011-07-19 |
| 7939072 | Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising same | Michael Sela | 2011-05-10 |
| 7498142 | Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodies | Michael Sela | 2009-03-03 |
| 7094882 | Growth factor which acts through erb b-4 rtk | Daniel Harari | 2006-08-22 |
| 6544759 | Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine | Daniel Harari | 2003-04-08 |